| Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ... American journal of respiratory and critical care medicine 194 (3), 265-275, 2016 | 1218 | 2016 |
| Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival MT Landi, T Dracheva, M Rotunno, JD Figueroa, H Liu, A Dasgupta, ... PloS one 3 (2), e1651, 2008 | 746 | 2008 |
| Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore TJ Franks, PY Chong, P Chui, JR Galvin, RM Lourens, AH Reid, E Selbs, ... Human pathology 34 (8), 743-748, 2003 | 483 | 2003 |
| Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study SLF Walsh, AU Wells, SR Desai, V Poletti, S Piciucchi, A Dubini, H Nunes, ... The lancet Respiratory medicine 4 (7), 557-565, 2016 | 429 | 2016 |
| Early immune-related adverse events and association with outcome in advanced non–small cell lung cancer patients treated with nivolumab: a prospective cohort study S Teraoka, D Fujimoto, T Morimoto, H Kawachi, M Ito, Y Sato, K Nagata, ... Journal of Thoracic Oncology 12 (12), 1798-1805, 2017 | 352 | 2017 |
| Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic … K Tamura, I Okamoto, T Kashii, S Negoro, T Hirashima, S Kudoh, ... British journal of cancer 98 (5), 907-914, 2008 | 271 | 2008 |
| Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary … BM Turner, PT Cagle, IM Sainz, J Fukuoka, SS Shen, J Jagirdar Archives of pathology & laboratory medicine 136 (2), 163-171, 2012 | 268 | 2012 |
| Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer J Fukuoka, T Fujii, JH Shih, T Dracheva, D Meerzaman, A Player, K Hong, ... Clinical cancer research 10 (13), 4314-4324, 2004 | 239 | 2004 |
| Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non–small-cell lung cancer tumors J Tsurutani, J Fukuoka, H Tsurutani, JH Shih, SM Hewitt, WD Travis, J Jen, ... Journal of clinical oncology 24 (2), 306-314, 2006 | 228 | 2006 |
| Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non–small cell lung cancer A Yoshizawa, J Fukuoka, S Shimizu, K Shilo, TJ Franks, SM Hewitt, T Fujii, ... Clinical Cancer Research 16 (1), 240-248, 2010 | 227 | 2010 |
| Imaging of pulmonary emphysema: a pictorial review M Takahashi, J Fukuoka, N Nitta, R Takazakura, Y Nagatani, Y Murakami, ... International journal of chronic obstructive pulmonary disease 3 (2), 193-204, 2008 | 173 | 2008 |
| Prognostic significance of NANOG and KLF4 for breast cancer T Nagata, Y Shimada, S Sekine, R Hori, K Matsui, T Okumura, S Sawada, ... Breast cancer 21, 96-101, 2014 | 170 | 2014 |
| Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non–small cell lung cancer SH Yang, LE Mechanic, P Yang, MT Landi, ED Bowman, J Wampfler, ... Clinical cancer research 11 (6), 2106-2110, 2005 | 168 | 2005 |
| Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients I Hwang, JW Kim, K Ylaya, EJ Chung, H Kitano, C Perry, J Hanaoka, ... Journal of translational medicine 18, 1-15, 2020 | 162 | 2020 |
| Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA M Kadota, M Sato, B Duncan, A Ooshima, HH Yang, N Diaz-Meyer, ... Cancer research 69 (18), 7357-7365, 2009 | 157 | 2009 |
| Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung K Whithaus, J Fukuoka, TJ Prihoda, J Jagirdar Archives of pathology & laboratory medicine 136 (2), 155-162, 2012 | 153 | 2012 |
| Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2 Y Zhou, N Yamada, T Tanaka, T Hori, S Yokoyama, Y Hayakawa, S Yano, ... Nature communications 6 (1), 7679, 2015 | 152 | 2015 |
| Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer RK Gill, SH Yang, D Meerzaman, LE Mechanic, ED Bowman, HS Jeon, ... Oncogene 30 (35), 3784-3791, 2011 | 149 | 2011 |
| Pathologic approach to pulmonary hemorrhage TV Colby, J Fukuoka, SP Ewaskow, R Helmers, KO Leslie Annals of diagnostic pathology 5 (5), 309-319, 2001 | 137 | 2001 |
| Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries S Mukhopadhyay, CF Farver, LT Vaszar, OJ Dempsey, HH Popper, ... Journal of clinical pathology 65 (1), 51-57, 2012 | 124 | 2012 |
Andrey Bychkov, MD, PhD, FRCPathKameda Medical CenterVerified email at kameda.jp
